[Skip to Content]
[Skip to Content Landing]
November 27, 1943


JAMA. 1943;123(13):857. doi:10.1001/jama.1943.02840480057022

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  Paul de Kruif's enthusiastic article in this month's Reader's Digest entitled "Hope for the Victims of Arthritis" might better have been called "False Hope for the Victims of Arthritis."Since its publication I have had many inquiries from all parts of the United States both from physicians and from patients with arthritis. Dr. de Kruif's paper concerns Ertron, a vitamin D preparation manufactured by the Nutrition Research Laboratories, Chicago, and reviews a report of Dr. R. Garfield Snyder, who for the past six years has conducted a study of this in various forms of arthritis.The objection which I have to the article in the Reader's Digest is that it stimulates great hope in the minds of patients with arthritis for a therapeutic agent of uncertain, if of any, permanent value, which is quite expensive, and the manufacturers of which have carried on a most intensive advertising

First Page Preview View Large
First page PDF preview
First page PDF preview